Product Reports Resources Pricing Login Book a demo

Standard Biotools

Biotech & Life Sciences · Boston, United States · Founded 1999 · IPO 2011

Biotech tools company that creates microfluidic-based chips and instrumentation for biological research

Revenue $83M

Investors

17 investors on Standard Biotools's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 17 investors entered at this stage
GE Equity
Smallcap World Fund
Alloy Ventures
EDBI
InterWest Partners
Versant Ventures
Lehman Brothers
Fidelity Contrafund
Wasatch Advisors
Caltech
California Institute of Technology
Invus
Bio*One Capital
Cross Creek
Lilly Ventures
EuclidSR Partners
Cross Creek Advisors

Global footprint

Where Standard Biotools has talent and traffic

Workforce by country
20 countries with
team presence
🇺🇸 United States46%
🇨🇦 Canada27.9%
🇸🇬 Singapore8.9%
🇬🇧 United Kingdom4%
🇫🇷 France2.9%
Top 5 of 20 shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States36.8%
🇨🇦 Canada11.1%
🇬🇧 United Kingdom9.5%
🇫🇷 France7.9%
🇯🇵 Japan7.9%
Top 5 markets shown

Talent graph

The shape of Standard Biotools's talent

Dealroom maps Standard Biotools's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Standard Biotools's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$68M patent portfolio · 62 active families

Estimated portfolio value
$68M
35.3× smaller than top peer Illumina ($2.4B)
62 active patent families
Where Standard Biotools innovates Mass Spectrometry-Mass SpectrometryMass analyzerMass cytometryMolecular biologyNucleic acid

Where Standard Biotools concentrates vs peers

Each axis is a top-10 topic across Standard Biotools and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Standard Biotools

An AI-synthesized read of the highest-engagement posts about Standard Biotools on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Standard Biotools on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.